rs971863968
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_005677.4(COLQ):c.157dupC(p.Leu53fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000186 in 1,614,086 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. LL53P?) has been classified as Pathogenic. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_005677.4 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COLQ | NM_005677.4 | c.157dupC | p.Leu53fs | frameshift_variant | 2/17 | ENST00000383788.10 | NP_005668.2 | |
COLQ | NM_080538.2 | c.127dupC | p.Leu43fs | frameshift_variant | 2/17 | NP_536799.1 | ||
COLQ | NM_080539.4 | c.157dupC | p.Leu53fs | frameshift_variant | 2/16 | NP_536800.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COLQ | ENST00000383788.10 | c.157dupC | p.Leu53fs | frameshift_variant | 2/17 | 1 | NM_005677.4 | ENSP00000373298.3 | ||
COLQ | ENST00000603808.5 | c.157dupC | p.Leu53fs | frameshift_variant | 2/17 | 1 | ENSP00000474271.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152204Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251400Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135876
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461882Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 727240
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152204Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74362
ClinVar
Submissions by phenotype
Congenital myasthenic syndrome 5 Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Nov 16, 2023 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 05, 2023 | This sequence change creates a premature translational stop signal (p.Leu53Profs*81) in the COLQ gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COLQ are known to be pathogenic (PMID: 22678886). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This premature translational stop signal has been observed in individuals with congenital myasthenic syndrome (PMID: 18180250, 23108489). This variant is also known as 158insC. ClinVar contains an entry for this variant (Variation ID: 468343). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Laboratorio de Biologia Molecular - Genetica, Hospital de Pediatria Garrahan | Dec 11, 2023 | This sequence change creates a premature translational stop signal, p.(Leu53Profs*81), within the COLQ gene that is expected to result in a truncated or absent protein. This variant has been observed in individuals diagnosed with congenital myasthenic syndrome (PMID: 18180250, 23108489), alternatively referred to as 158insC (PMID: 18180250). Based on these findings, the variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at